Drug intelligence / Profile preview

MTI980

Development stage
Unknown
Lead developer
TRX Biosciences
Modality
Small Molecules
Administration
Oral
01

Overview

MTI980 is a lipid-based oral formulation of **estetrol** (E4), a naturally occurring estrogen, developed by **TRX Biosciences** in collaboration with **Mithra Pharmaceuticals**. The drug utilizes TRX Biosciences' proprietary **TRX™ technology**, which is designed to enhance the oral bioavailability and potentially the blood-brain barrier penetration of lipophilic compounds. MTI980 is being developed for the treatment of **central nervous system (CNS) diseases**, with a primary focus on **neonatal hypoxic-ischemic encephalopathy (HIE)**. Estetrol acts as a **Native Estrogen with Selective action in Tissues (NEST)**, exhibiting agonist activity on estrogen receptors in the brain, which is thought to provide neuroprotective effects. It is currently in **Phase 2/3** development.

Other names
estetrol lipid formulationTRX-enabled estetrol
02

Targets

ESR1 (ERα)ESR2 (ERβ)

Beyond the preview

Go deeper on MTI980.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MTI980.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call